![](/wp-content/themes/basic-child/images/print.png)
New Lyme Vaccine in Clinical Trials: Update!
![syringe](https://lymediseaseassociation.org/wp-content/uploads/2018/07/syringe.jpg)
An article on a new vaccine for Lyme disease, “New Effort for Lyme Disease Vaccine Draws Early Fire,” by Sumathi Reddy, appeared in the Wall Street Journal on July 9, […]
An article on a new vaccine for Lyme disease, “New Effort for Lyme Disease Vaccine Draws Early Fire,” by Sumathi Reddy, appeared in the Wall Street Journal on July 9, […]
ClinicalTrials.gov is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). Clinical trials are scientific studies conducted to find new treatments and drugs for […]
Since the publication of a number of peer reviewed studies on Lyme disease long-term treatment trials funded by the National Institutes of Health (NIH), many articles and letters continue to […]
Northeastern Global News (6.28.2024) published the article, “A Lyme vaccine is in late-stage trials. Could an anti-tick vaccine be next?” As a vaccine for Lyme disease enters late-stage clinical trials, researchers are exploring the possibility of an anti-tick vaccine to protect against various tick-borne diseases. This research focuses on a phenomenon called acquired tick resistance (ATR), where repeated tick infestations lead to an immune response that causes ticks to fall off and die when attempting to feed on the host.
JAMA (Yang, Y., et al. )10. 24. 2023 published an original investigation “Traditional Chinese Medicine Compound (Tongxinluo) and Clinical Outcomes of Patients With Acute Myocardial Infarction: The CTS-AMI Randomized Clinical Trial.” Investigators of this clinical study conducted a randomized, double-blind, placebo-controlled clinical trial of 3777 patients with acute ST-segment elevation myocardial infarction (STEMI). Patients from 124 hospitals in China presenting with STEMI between May-December 2020 were given either oral Tongxinluo or placebo within 24 hours of symptom onset. The adjunctive treatment or placebo was administered for 12 months, and positive patient outcome was observed.
Reuters published an update on Pfizer’s Lyme vaccine trials (10.11.2023), “FDA finds no misconduct at trial sites for Pfizer’s Lyme disease shot, Care Access says.” According to the article, the third party contract research firm, Care Access, has said that the FDA regulator did not find any misconduct at clinical sites managed by Care Access for Pfizer/Valneva’s trial of a Lyme disease vaccine candidate.
An article in Martha Vineyard Times announced that phase 3 trials for the Valneva-Pfizer Lyme disease vaccine candidate, VLA15, will take place on the Vineyard. This trial phase will investigate the extent to which the vaccine provides protection.
A new center at Columbia University will open this summer to patients. The Cohen Center for Health & Recovery from Tick-Borne Diseases has been established through a $16M grant from […]
On March 7, 2024 a small group of expert-advocates were convened to compile a list of individual questions that they have about a future Lyme disease vaccine, and the VLA15 vaccine in particular, given it was the only vaccine candidate being evaluated in phase ‘ clinical trials as of the date of this meeting. Pat Smith reported on this meeting in the President’s Blog – In-depth Synopsis of Advocate Vaccine Meeting Hosted by CDC. The following is a list of all the questions contributed by the participants of the meeting. These questions were shared with a Pfizer representative on March 8, 2024. As of April 30, 2024, there has been no response by Pfizer.
Brian A Fallon, MD, MPH
Conference Co-Director
Conference Planning Committee
Professor, Clinical Psychiatry, Columbia University Irving Medical Center (CUIMC), NYC, NY
Director, Lyme & Tick-borne Diseases Research Center, CUIMC, NYC, NY
Director, Clinical Trials Coordinating Center for Lyme & Other Tick-borne Diseases at CUIMC, NYC, NY
Director, Center for Neuroinflammatory and Somatic Disorders, New York State Psychiatric Institute, NYC, NY
Long COVID and Long Lyme: Mental Health Implications
LDA Doctor Referral System © Terms & Conditions and Guidelines
Save this Information for Your Records:
About LDA DOCTOR REFERRAL SYSTEM ©
Welcome to the Lyme Disease Association’s LDA Doctor Referral System ©. LDA made updates and enhancements to its prior system and has launched a new site to provide patients with information about doctors, other practitioners, testing labs, and pharmacies that are knowledgeable about chronic Lyme disease and often about many other tick-borne diseases (TBD). Many of the doctors listed are often referred to as Lyme Literate Physicians/Doctors (LLMD). Tens of thousands of patients have successfully used the prior LDA system to locate Lyme and TBD resources.
Terms & Conditions and Guidelines
Because there is a negative political climate surrounding Lyme disease, many LLMDs do not want their names posted outright on the internet. LDA has tried to balance the doctors’ wishes with patients’ need to find a doctor. This new system is a result of that compromise and therefore:
Because of the limited number of physicians treating chronic Lyme disease nationwide, some states, and in some instances, entire regions, may not have any treating physicians who follow flexible treating approaches such as those in the International Lyme & Associated Diseases Society (ILADS) Guidelines, Evidence Assessments and Guideline Recommendations in Lyme Disease: The Clinical Management of Known Tick Bites, Erythema Migrans Rashes and Persistent Disease. In the event that the LDA Doctor Referral System © contains no Lyme or TBD resource listings in a given area, the closest possible option(s) will populate based on the location entered and specaialty/ies selected. The LDA appreciates any changes in provider information that you may find and make us aware of so we can investigate.
Some providers may not specifically treat Lyme and TBD but see patients who have symptoms associated with Lyme and TBD to address those specific symptoms. Contact the provider to confirm.
It is your responsibility to contact the provider’s office to confirm the current address, directions, nature of services provided, and all other provider information before you make an appointment.
DISCLAIMER: The Lyme Disease Association, Inc. provides referrals to health care providers who treat Lyme disease, and often other TBD, as a courtesy to those seeking Lyme Literate Physicians (LLMD). However, some of the providers included do not specifically treat Lyme and TBD but see patients who have symptoms associated with Lyme and TBD to address those specific symptoms. We do not evaluate the professional competence or qualifications of health care providers on our referral list or the costs of services provided. Accordingly, the LDA neither warrants nor endorses the health care providers contained on this list nor the quality of care you will receive from those providers. We do not make recommendations, only referrals. LDA does not receive any monies from physicians to be included on this list nor does LDA provide any monies to physicians. Because of the limited number of physicians treating chronic Lyme disease nationwide, some states, and in some instances, entire regions, may not have any treating physicians who follow flexible treating approaches such as those in the International Lyme & Associated Diseases Society (ILADS) Guidelines: Evidence Assessments and Guideline Recommendations in Lyme Disease: The Clinical Management of Known Tick Bites, Erythema Migrans Rashes and Persistent Disease. In the event that the Doctor Referral System contains no Lyme or TBD resource listings in a given area, the closest possible option(s) will populate based on the zip code entered and category/ies selected. The LDA appreciates any changes in provider information that you may find and make us aware of.
LDA does not accept or reply to any comments on:
We cannot guarantee that the information provided will be timely and accurate or that physicians on the list are accepting new patients, or that they accept insurance. The selection of a physician should be made by you after careful consideration. There are two approaches in the treatment of Lyme disease. Our list contains physicians who generally follow more flexible treatment approaches than those advocated by the Infectious Diseases Society of America (IDSA). LDA is not responsible for incorrect information on the website. BEFORE DOCTOR VISIT: Please contact the physicians’ offices directly to confirm their current address, directions, and any other necessary information before scheduling an appointment. Do not rely only on the maps provided on this site. The maps on LDA’s Doctor Referral System are for informational purposes and provide an approximate locality of the listing based on the addresses we are provided with at the time of site updates. Practitioners often relocate and addresses can change. Notification of changes in listed information can be updated on our Dr. Referral Contact Form. Thank you, Lyme Disease Association, Inc. (LDA)
Subscriber information will not be shared outside of the Lyme Disease Association, Inc. nor used for donor solicitation.
The Lyme Disease Association, Inc. reserves the right to unsubscribe anyone from this service without cause.